Insider Transactions in Q1 2021 at Elevance Health, Inc. (ELV)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2021
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
59,500
-15.49%
|
$20,765,500
$349.35 P/Share
|
|
Mar 22
2021
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct |
38,093
+21.14%
|
$5,294,927
$139.36 P/Share
|
|
Mar 05
2021
|
Ronald W Penczek CAO & Controller |
SELL
Open market or private sale
|
Direct |
2,068
-39.73%
|
$688,644
$333.94 P/Share
|
|
Mar 04
2021
|
Ronald W Penczek CAO & Controller |
SELL
Open market or private sale
|
Direct |
67
-1.27%
|
$21,641
$323.56 P/Share
|
|
Mar 02
2021
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-1.11%
|
$153,012
$311.66 P/Share
|
|
Mar 02
2021
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
296
-0.96%
|
$92,056
$311.66 P/Share
|
|
Mar 02
2021
|
Leah Stark EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
715
-5.26%
|
$222,365
$311.66 P/Share
|
|
Mar 02
2021
|
Prakash R Patel EVP & President, DBG |
SELL
Payment of exercise price or tax liability
|
Direct |
551
-2.59%
|
$171,361
$311.66 P/Share
|
|
Mar 02
2021
|
Gloria M Mccarthy EVP & Chief Administrative Off |
SELL
Payment of exercise price or tax liability
|
Direct |
536
-0.95%
|
$166,696
$311.66 P/Share
|
|
Mar 02
2021
|
Ronald W Penczek CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
42
-0.79%
|
$13,062
$311.66 P/Share
|
|
Mar 02
2021
|
John E Gallina EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
483
-0.88%
|
$150,213
$311.66 P/Share
|
|
Mar 02
2021
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,644
-1.61%
|
$511,284
$311.66 P/Share
|
|
Mar 01
2021
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Grant, award, or other acquisition
|
Direct |
26,032
+23.01%
|
-
|
|
Mar 01
2021
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
14,231
-43.6%
|
$4,425,841
$311.48 P/Share
|
|
Mar 01
2021
|
Felicia F Norwood EVP & President,Gov Health Ben |
BUY
Grant, award, or other acquisition
|
Direct |
14,641
+20.3%
|
-
|
|
Mar 01
2021
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-1.34%
|
$68,420
$311.48 P/Share
|
|
Mar 01
2021
|
Leah Stark EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,806
+11.72%
|
-
|
|
Mar 01
2021
|
Leah Stark EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
158
-1.32%
|
$49,138
$311.48 P/Share
|
|
Mar 01
2021
|
Jeffrey D. Alter EVP, IngenioRx & Anthem Health |
BUY
Grant, award, or other acquisition
|
Direct |
2,649
+32.93%
|
-
|
|
Mar 01
2021
|
Prakash R Patel EVP & President, DBG |
BUY
Grant, award, or other acquisition
|
Direct |
9,866
+19.98%
|
-
|
|
Mar 01
2021
|
Prakash R Patel EVP & President, DBG |
SELL
Payment of exercise price or tax liability
|
Direct |
186
-1.6%
|
$57,846
$311.48 P/Share
|
|
Mar 01
2021
|
Gloria M Mccarthy EVP & Chief Administrative Off |
BUY
Grant, award, or other acquisition
|
Direct |
26,032
+18.56%
|
-
|
|
Mar 01
2021
|
Gloria M Mccarthy EVP & Chief Administrative Off |
SELL
Payment of exercise price or tax liability
|
Direct |
11,971
-28.44%
|
$3,722,981
$311.48 P/Share
|
|
Mar 01
2021
|
Ronald W Penczek CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,895
+21.57%
|
-
|
|
Mar 01
2021
|
Ronald W Penczek CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
818
-25.27%
|
$254,398
$311.48 P/Share
|
|
Mar 01
2021
|
John E Gallina EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,232
+19.23%
|
-
|
|
Mar 01
2021
|
John E Gallina EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,633
-27.12%
|
$3,306,863
$311.48 P/Share
|
|
Mar 01
2021
|
Blair Williams Todt EVP, CLO & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,007
+41.72%
|
-
|
|
Mar 01
2021
|
Gail Boudreaux President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
83,835
+34.38%
|
-
|
|
Mar 01
2021
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,564
-66.26%
|
$11,060,404
$311.48 P/Share
|
|
Feb 04
2021
|
Ryan M. Schneider Director |
BUY
Open market or private purchase
|
Direct |
1,700
+36.79%
|
$503,200
$296.03 P/Share
|